Time: 11:15

Looking for political…

Research Australia has expressed concern over the fate of the $20 billion Medical Research Future Fund. In the last week of the election campaign, the organisation that represents around 160 health and medical research organisations questioned the commitment of political…

Read More...
Looking for political commitment on MRFF
Research Australia has expressed concern over the fate of the $20 billion Medical Research Future…

Early-bird rates for…

Two weeks are remaining to take advantage of AusBiotech’s early-bird rate for International BioFest 2016, which closes Friday 15 July, which will see the largest gathering of life sciences ever staged in Australia and feature a world-class speaking program. With…

Read More...
Early-bird rates for International BioFest 2016 closing…
Two weeks are remaining to take advantage of AusBiotech’s early-bird rate for International BioFest 2016,…

Clarity awarded $2.5…

Clarity Pharmaceuticals, an Australian radiopharmaceutical company focused on the treatment of serious diseases, especially cancer, has been awarded a Cooperative Research Centres Projects (CRC-P) grant. Clarity said it will use the $2.5 million grant to further develop SARTATE in a second indication, following its successful…

Read More...
Clarity awarded $2.5 million CRC-Projects Grant
Clarity Pharmaceuticals, an Australian radiopharmaceutical company focused on the treatment of serious diseases, especially cancer, has…

Latest News

28 June 2016Latest News

Looking for political commitment on MRFF

Research Australia has expressed concern over the fate of the $20 billion Medical Research Future Fund. In the last week…

28 June 2016Latest News

Early-bird rates for International BioFest 2016 closing…

Two weeks are remaining to take advantage of AusBiotech’s early-bird…

28 June 2016Company News

Clarity awarded $2.5 million CRC-Projects Grant

Clarity Pharmaceuticals, an Australian radiopharmaceutical company focused on the treatment of…

28 June 2016Company News

Avita Medical receives BARDA extension deal

A US Federal authority charged with supporting development of medical countermeasures for possible mass casualty events has agreed to fund…

28 June 2016Company News

ATL1103 for acromegaly granted orphan status in…

Antisense Therapeutics (ASX:ANP) has announced that the European Commission has…

23 June 2016Policy

Government advice confirmed trade reality

Legal advice provided to the former federal government confirmed that…

23 June 2016Latest News

TGA provides guidance on Annual Charge Exemption

The annual charge exemption (ACE) scheme replaced the Therapeutic Goods…

23 June 2016Company News

New patent for Neuren’s trofinetide

Melbourne-based Neuren Pharmaceuticals (ASX:NEU) announced that IP Australia has issued a Notice of Grant for a new patent that covers the…

23 June 2016Company News

Prima BioMed announces first data from AIPAC…

Immuno-oncology company Prima BioMed (ASX:PRR) has announced initial safety data from…